HealthViiV-Funded Claims Studies Link Apretude PrEP Shots to Few HIV Cases and Steadier UseViiV funded two Apretude studies using insurance claims. The findings point to steadier PrEP use, while doctors describe barriers to getting injections.Oct. 30, 2026